Certara是一家药物研究公司,收到1 356万美元的投资,使股票存量增加442.2 %。 Certara, a drug research firm, receives $13.56 million in investments, pushing its stock up 442.2%.

Samjo管理有限责任公司和Exodus Point资本管理有限责任公司最近投资Certara公司,该公司为药物研究与开发提供软件和服务。 Samjo Management LLC and ExodusPoint Capital Management LP have recently invested in Certara, Inc., a company that provides software and services for drug research and development. Samjo投资202万美元,ExodusPoint投资1 154万美元。 Samjo invested $2.02 million, while ExodusPoint invested $11.54 million. Certara的股票在第四季度增长了442.2 % , 目前股价为15.83美元, Certara's stock has seen a 442.2% increase in the fourth quarter, and it currently holds a "Moderate Buy" rating with a target price of $15.83.